Literature DB >> 25302217

Comparison of Directly Observed Treatment Short Course (DOTS) with Self-Administered Therapy in Pulmonary Tuberculosis in Udupi District of Southern India.

Amrita Parida1, K L Bairy2, Bharti Chogtu3, Rahul Magazine4, Sudha Vidyasagar5.   

Abstract

BACKGROUND: Directly observed treatment short course (DOTS) and self-administered therapy (SAT) are the treatment options available for tuberculosis (TB). Studies conducted worldwide have shown difference in treatment outcome with these two treatment modalities. AIM: The study was undertaken to compare treatment outcome of DOTS and SAT in patients of pulmonary TB taking SAT from a tertiary care hospital and DOTS from the DOTS centre of a government hospital.
MATERIALS AND METHODS: It was a retrospective comparative study. The case record files of patients with pulmonary TB diagnosed from March 2011 to February 2012 were analysed as per the proforma. The sample size of patients was 150 (75 each from DOTS and SAT).
RESULTS: The treatment outcome in DOTS group was cured 70.7%, treatment completed 1.3%, failure 5.3%, deaths 10.7%, defaulters 8% and transferred out 4% whereas in SAT group, cure was seen in 68% and 4% completed the treatment, 1.3% had treatment failure, and 26.7% were lost to follow up which included deaths, defaulters and those patients who switched over to other hospitals. The treatment success rate was similar (72%) in both groups. There was no statistically significant difference observed in the average weight gain at the end of treatment between the two groups. A total of 11 adverse drug reactions (4 DOTS, 7 SAT) were recorded in the study.
CONCLUSION: The study shows no statistically significant difference between success rate in patients taking DOTS and SAT.

Entities:  

Keywords:  Cure; Defaulters; Treatment completed; Treatment failure; Treatment success; Tuberculosis

Year:  2014        PMID: 25302217      PMCID: PMC4190739          DOI: 10.7860/JCDR/2014/8865.4721

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  Directly observed therapy.

Authors:  J Volmink; P Garner
Journal:  Lancet       Date:  1997-05-10       Impact factor: 79.321

2.  Effectiveness of the direct observation component of DOTS for tuberculosis: a randomised controlled trial in Pakistan.

Authors:  J D Walley; M A Khan; J N Newell; M H Khan
Journal:  Lancet       Date:  2001-03-03       Impact factor: 79.321

3.  Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania.

Authors:  N Kennedy; A Ramsay; L Uiso; J Gutmann; F I Ngowi; S H Gillespie
Journal:  Trans R Soc Trop Med Hyg       Date:  1996 Mar-Apr       Impact factor: 2.184

4.  Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000.

Authors:  T Santha; R Garg; T R Frieden; V Chandrasekaran; R Subramani; P G Gopi; N Selvakumar; S Ganapathy; N Charles; J Rajamma; P R Narayanan
Journal:  Int J Tuberc Lung Dis       Date:  2002-09       Impact factor: 2.373

5.  Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara.

Authors:  Anupa Khadka Chhetri; Anupa Khatri Chhetri; Archana Saha; Sharat Chandra Verma; Subish Palaian; Pranaya Mishra; Pathiyil Ravi Shankar
Journal:  J Pak Med Assoc       Date:  2008-10       Impact factor: 0.781

6.  Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS).

Authors:  M Vasantha; P G Gopi; R Subramani
Journal:  Indian J Tuberc       Date:  2009-01

Review 7.  Directly observed therapy for treating tuberculosis.

Authors:  J Volmink; P Garner
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

8.  Survival of tuberculosis patients treated under DOTS in a rural Tuberculosis Unit (TU), south India.

Authors:  M Vasantha; P G Gopi; R Subramani
Journal:  Indian J Tuberc       Date:  2008-04

9.  DOTS versus self administered therapy (SAT) for patients of pulmonary tuberculosis: a randomised trial at a tertiary care hospital.

Authors:  Monika Tandon; M Gupta; S Tandon; K B Gupta
Journal:  Indian J Med Sci       Date:  2002-01

10.  Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis.

Authors:  Antonio Bernabe-Ortiz; Cesar P Carcamo; Juan F Sanchez; Julia Rios
Journal:  PLoS One       Date:  2011-04-08       Impact factor: 3.240

  10 in total
  2 in total

1.  Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.

Authors:  Vijayashree Yellappa; Pierre Lefèvre; Tullia Battaglioli; Devadasan Narayanan; Patrick Van der Stuyft
Journal:  BMC Health Serv Res       Date:  2016-07-19       Impact factor: 2.655

Review 2.  Tuberculosis treatment.

Authors:  Marcelo Fouad Rabahi; José Laerte Rodrigues da Silva Júnior; Anna Carolina Galvão Ferreira; Daniela Graner Schuwartz Tannus-Silva; Marcus Barreto Conde
Journal:  J Bras Pneumol       Date:  2017 Nov-Dec       Impact factor: 2.624

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.